CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL revenue by segment, product and geography
In its fiscal year ending 2025-12-31, CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported revenue across 3 business segments; the largest, Discovery And Safety Assessment Segment, was $2.4B, 59.8% of the filed sum (-2.0% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Discovery And Safety Assessment Segment$2.4B59.8%-2.0% yoy
- Research Models And Services Segment$846M21.1%+2.0% yoy
- Manufacturing Support Segment$766M19.1%-0.4% yoy
Members sum to the consolidated $4.02B for this period.
- Service$3.25B80.9%-1.6% yoy
- Product$765M19.1%+2.6% yoy
Members sum to the consolidated $4.02B for this period.
- United States$2.14B53.3%-4.4% yoy
- Europe$1.1B27.5%+2.3% yoy
- Canada$501M12.5%+3.9% yoy
- Asia Pacific$205M5.1%+4.1% yoy
- Other$64.9M1.6%+22.8% yoy
Members sum to the consolidated $4.02B for this period.
- Discovery And Safety Assessment Segment$597M59.9%+0.7% yoy
- Research Models And Services Segment$208M20.9%-2.2% yoy
- Manufacturing Support Segment$191M19.1%+6.8% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.